Christoph Lindner

702 total citations
15 papers, 286 citations indexed

About

Christoph Lindner is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Christoph Lindner has authored 15 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Christoph Lindner's work include Breast Cancer Treatment Studies (5 papers), Advanced Breast Cancer Therapies (3 papers) and Cancer Treatment and Pharmacology (3 papers). Christoph Lindner is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Advanced Breast Cancer Therapies (3 papers) and Cancer Treatment and Pharmacology (3 papers). Christoph Lindner collaborates with scholars based in Germany, Switzerland and United Kingdom. Christoph Lindner's co-authors include Adam Grundhoff, Ilona Hauber, Evelin Schröck, Axel Schambach, Joachim Hauber, Jan Chemnitz, Frank Buchholz, Karl Hackmann, Ulrike C. Lange and Josephine Abi‐Ghanem and has published in prestigious journals such as Journal of Clinical Oncology, Nature Biotechnology and PLoS Pathogens.

In The Last Decade

Christoph Lindner

15 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christoph Lindner Germany 8 161 67 49 48 47 15 286
Rena Levin-Klein Israel 9 275 1.7× 54 0.8× 49 1.0× 56 1.2× 59 1.3× 11 378
Mónika Ádori Sweden 11 90 0.6× 106 1.6× 21 0.4× 34 0.7× 62 1.3× 28 422
Rajeev K. Boregowda United States 9 203 1.3× 61 0.9× 30 0.6× 60 1.3× 28 0.6× 14 407
Abby M. Green United States 10 225 1.4× 121 1.8× 36 0.7× 61 1.3× 44 0.9× 23 368
Federica Alessandrini Italy 9 143 0.9× 75 1.1× 17 0.3× 57 1.2× 65 1.4× 13 319
Xiaomei Jin China 10 189 1.2× 163 2.4× 33 0.7× 64 1.3× 107 2.3× 16 413
Theres Oakes United Kingdom 9 140 0.9× 117 1.7× 32 0.7× 11 0.2× 33 0.7× 12 435
Susanne Oberle Switzerland 10 126 0.8× 252 3.8× 31 0.6× 29 0.6× 16 0.3× 12 630
Doug Schneider United States 6 82 0.5× 27 0.4× 23 0.5× 20 0.4× 93 2.0× 10 269
Aya Obata-Onai Japan 5 143 0.9× 114 1.7× 12 0.2× 32 0.7× 16 0.3× 5 993

Countries citing papers authored by Christoph Lindner

Since Specialization
Citations

This map shows the geographic impact of Christoph Lindner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Lindner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Lindner more than expected).

Fields of papers citing papers by Christoph Lindner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Lindner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Lindner. The network helps show where Christoph Lindner may publish in the future.

Co-authorship network of co-authors of Christoph Lindner

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Lindner. A scholar is included among the top collaborators of Christoph Lindner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Lindner. Christoph Lindner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ulm, Bernhard, et al.. (2021). Altona Prognostic Index: A New Prognostic Index for ER-Positive and Her2-Negative Breast Cancer of No Special Type. Cancers. 13(15). 3799–3799. 3 indexed citations
2.
3.
Wesselmann, Simone, Clara Breidenbach, Jens‐Uwe Blohmer, et al.. (2021). Trastuzumab treatment of patients with early, HER2-positive breast cancer in 17 certified German breast cancer centers. Journal of Cancer Research and Clinical Oncology. 148(3). 719–726. 1 indexed citations
4.
Friedrichs, Kay, et al.. (2020). Desmoid Type Fibromatosis of the Breast: Ten-Year Institutional Results of Imaging, Histopathology, and Surgery. Breast Care. 16(1). 77–84. 22 indexed citations
5.
Lohmeyer, Jörn Andreas, et al.. (2020). Zur Therapie von Phylloides-Tumoren der Brust – eine Aufarbeitung von 66 Fällen mit Literaturübersicht. Handchirurgie · Mikrochirurgie · Plastische Chirurgie. 53(2). 159–167. 2 indexed citations
6.
Hackethal, Andreas, Markus Hirschburger, Sven Oliver Eicker, et al.. (2018). Role of Indocyanine Green in Fluorescence Imaging with Near-Infrared Light to Identify Sentinel Lymph Nodes, Lymphatic Vessels and Pathways Prior to Surgery – A Critical Evaluation of Options. Geburtshilfe und Frauenheilkunde. 78(1). 54–62. 25 indexed citations
7.
8.
Hauber, Ilona, Jan Chemnitz, Carola Schäfer, et al.. (2016). Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity. Nature Biotechnology. 34(4). 401–409. 95 indexed citations
9.
Bendrat, Klaus, Péter Fritz, Simon Müller, et al.. (2016). Improved Risk Stratification for Breast Cancer Samples Based on the Expression Ratio of the Estrogen and Progesterone Receptor.. PubMed. 36(8). 3855–63. 2 indexed citations
10.
Lindner, Christoph, et al.. (2015). An extraocular non-invasive transscleral LED-endoilluminator for eye speculum integration. Graefe s Archive for Clinical and Experimental Ophthalmology. 253(9). 1529–1535. 6 indexed citations
11.
Gluz, Oleg, Ulrike Nitz, Matthias Christgen, et al.. (2015). Efficacy of 12 weeks neoadjuvant nab-paclitaxel combined with carboplatinum vs. gemcitabine in triple-negative breast cancer: WSG-ADAPT TN randomized phase II trial.. Journal of Clinical Oncology. 33(15_suppl). 1032–1032. 10 indexed citations
12.
Fritz, Péter, Klaus Bendrat, Maike Sonnenberg, et al.. (2014). Tubular breast cancer. A retrospective study.. PubMed. 34(7). 3647–56. 11 indexed citations
13.
Hauber, Ilona, Jan Chemnitz, Janet Chusainow, et al.. (2013). Highly Significant Antiviral Activity of HIV-1 LTR-Specific Tre-Recombinase in Humanized Mice. PLoS Pathogens. 9(9). e1003587–e1003587. 47 indexed citations
14.
Woelber, Linn, Jan Felix Kersten, Matthias Choschzick, et al.. (2011). Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer. BMC Cancer. 11(1). 12–12. 46 indexed citations
15.
Krüger, William, Florian Tögel, Nicolaus Kröger, et al.. (1999). Tumour cell detection in G-CSF mobilised stem cell harvests of patients with breast cancer. Medical Oncology. 16(1). 17–22. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rena Levin-Klein Breakdown of academic impact, for papers by Mónika Ádori Breakdown of academic impact, for papers by Rajeev K. Boregowda Breakdown of academic impact, for papers by Abby M. Green Breakdown of academic impact, for papers by Federica Alessandrini Breakdown of academic impact, for papers by Xiaomei Jin Breakdown of academic impact, for papers by Theres Oakes Breakdown of academic impact, for papers by Susanne Oberle Breakdown of academic impact, for papers by Doug Schneider Breakdown of academic impact, for papers by Aya Obata-Onai
Rankless by CCL
2026